<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb1655">
 <element-citation publication-type="journal" id="rf1635">
  <person-group person-group-type="author">
   <name>
    <surname>Yokomizo</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Miyamoto</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Nagao</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Kumagae</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Habib</surname>
    <given-names>E.-S.E.</given-names>
   </name>
   <name>
    <surname>Suzuki</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Harada</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Uyeda</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Fattiviracin A1, a novel antiviral agent produced by 
   <italic>Streptomyces microflavus</italic> strain no. 2445. II. Biological properties
  </article-title>
  <source>J. Antibiot.</source>
  <volume>51</volume>
  <issue>11</issue>
  <year>1998</year>
  <fpage>1035</fpage>
  <lpage>1039</lpage>
  <pub-id pub-id-type="doi">10.7164/antibiotics.51.1035</pub-id>
 </element-citation>
</ref>
